Galectin-3: An Early Marker of Gestational Diabetes, Subclinical Atherosclerosis, and Tumor Progression
- PMID: 30791704
- DOI: 10.1177/0003319719831870
Galectin-3: An Early Marker of Gestational Diabetes, Subclinical Atherosclerosis, and Tumor Progression
Comment on
-
Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study.Angiology. 2019 Jan;70(1):47-55. doi: 10.1177/0003319718780772. Epub 2018 Jun 7. Angiology. 2019. PMID: 29879846 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
